Sarcoma  >>  AiRuiKang (dalpiciclib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AiRuiKang (dalpiciclib) / Jiangsu Hengrui Pharma
NCT05952128: Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic Sarcoma

Recruiting
2
50
RoW
Fluzoparib+ Dalpiciclib
Sun Yat-sen University, Jiangsu Hengrui Pharmaceutical Co., Ltd.
Sarcoma
12/24
12/25

Download Options